5月27日中欧医疗创新股票A净值增长2.16%，今年来累计上涨23.16%

Group 1 - The core viewpoint of the news is the performance and holdings of the China Europe Medical Innovation Stock A fund, which has shown significant growth in recent months and year-to-date [1] - As of May 27, 2025, the latest net value of the fund is 1.2806 yuan, reflecting a growth of 2.16% [1] - The fund's one-month return is 4.86%, ranking 291 out of 1022 in its category, while the six-month return is 17.27%, ranking 46 out of 987 [1] - Year-to-date, the fund has achieved a return of 23.16%, ranking 32 out of 999 [1] Group 2 - The top ten holdings of the China Europe Medical Innovation Stock A fund account for a total of 75.62%, with major positions including WuXi AppTec (10.35%), Kelun-Biotech (10.15%), and WuXi Biologics (9.82%) [1] - The fund was established on February 28, 2019, and as of March 31, 2025, it has a total scale of 4.675 billion yuan [1] - The fund manager is Ms. Ge Lan, who has extensive experience in the investment management field [2]